Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
31
07
2018
revised:
12
09
2018
accepted:
17
09
2018
pubmed:
30
9
2018
medline:
21
10
2020
entrez:
30
9
2018
Statut:
ppublish
Résumé
For chronic hepatitis B patients, hepatitis B e antigen (HBeAg) seroclearance signals a transition from an immunologically active phase to an inactive carrier state with a reduction in hepatitis B virus (HBV) DNA levels and a reduced risk of hepatocellular carcinoma (HCC).
Identifiants
pubmed: 30267868
pii: S1542-3565(18)31028-0
doi: 10.1016/j.cgh.2018.09.037
pii:
doi:
Substances chimiques
DNA, Viral
0
Hepatitis B Antibodies
0
Hepatitis B Surface Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1413-1415Informations de copyright
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.